Patent ID: 11950875
Assignee: ABBOTT DIABETES CARE INC.
Field: Medical technology (Instruments)
Classification: CPC A  G  H  Y | IPC A  H

Claim 7:
8. A method for preventing injection of medication when an adverse condition is present, the method comprising:
receiving, by the medication delivery device, data indicative of an analyte level from a sensor control device configured to be worn by a user;
determining, by the medication delivery device, whether the received data indicative of the analyte level includes recent analyte level data;
receiving, by the medication delivery device, an alert indicative of an adverse condition associated with the user;
determining whether the adverse condition is present based on the received data indicative of the analyte level; and
in response to either a determination that the received data indicative of the analyte level does not include the recent analyte level data, or a determination that the adverse condition is present, activating a lock-out mechanism for a predetermined duration of time and outputting a warning to the user, wherein the lock-out mechanism is configured to prevent use of the medication delivery device, wherein the medication delivery device is an insulin pen, and wherein the lock-out mechanism comprises a latch mechanism configured to prevent activation of the medication delivery device for the predetermined duration of time.